Company intelligence / Profile preview

GSI Technology

Sunnyvale, California, United Stateslinkedin.com ↗

Ownership: Public · GSIT
Employees: ~158
Development stage: Commercial

Overview

GSI Technology develops and markets high-performance semiconductor memory solutions and custom AI processors. Their APU technology accelerates similarity search in large databases, with applications in drug discovery informatics but does not itself constitute a therapeutic pipeline. No clinical results as the company does not develop drugs or biologics.

Industry: Drug Discovery Services

Partnerships

Collaborations with major academic and research institutions for cheminformatics/drug discovery software integration

Financials

Market cap: $216M
Total revenue: $6.3M
Enterprise value: $147.2M

Beyond the preview

Go deeper on GSI Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GSI Technology.

Explore the full profile